Annals of internal medicine
-
Randomized Controlled Trial Multicenter Study Comparative Study
Age- and Weight-Adapted Dose of Prasugrel Versus Standard Dose of Ticagrelor in Patients With Acute Coronary Syndromes: Results From a Randomized Trial.
The efficacy and safety of a reduced dose of prasugrel versus a standard dose of ticagrelor in elderly patients or those with a low body weight presenting with an acute coronary syndrome (ACS) are unknown. ⋯ German Center for Cardiovascular Research and Deutsches Herzzentrum München.